Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. |
2024-08-08 |
Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB". |
2024-07-10 |
HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
Genovis AB. (7/4/24). "Press Release: Genovis Completes a Strategic Investment in Sequrna, a Developer of Next-generation RNase Inhibitors". Ghent. |
2024-07-04 |
Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. |
2024-06-20 |
Hikma Pharmaceuticals plc. (6/17/24). "Press Release: Hikma Acquires Xellia’s Differentiated Portfolio and Enhances Injectables Pipeline, Manufacturing Capabilities and R&D". London. |
2024-06-17 |
Coulter Partners. (6/12/24). "Press Release: Coulter Partners Announces Leadership Transition and Senior Leadership Team (SLT) Reorganization: Co-founder Bianca Coulter Becomes Executive Chair, Nicholas Green Appointed CEO". |
2024-06-12 |
Moleculent AB. (6/11/24). "Press Release: Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication". Stockholm. |
2024-06-11 |
Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |
Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. |
2024-06-03 |
BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. |
2024-05-29 |
Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. |
2024-05-28 |
Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. |
2024-05-21 |
Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. |
2024-05-15 |
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. |
2024-05-13 |
H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". |
2024-05-13 |
Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. |
2024-05-09 |
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. |
2024-05-07 |
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki. |
2024-04-11 |
Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. |
2024-03-26 |
CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. |
2024-03-26 |
Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. |
2024-03-25 |
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. |
2024-03-21 |
Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". |
2024-03-15 |
Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. |
2024-03-14 |
Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. |
2024-03-14 |
Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. |
2024-03-14 |
Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. |
2024-03-13 |
Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". |
2024-02-29 |
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
Commit Biologics ApS. (2/14/24). "Press Release: Commit Biologics Receives Innobooster Grant from Innovation Fund Denmark Funding". |
2024-02-14 |
FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". |
2024-02-01 |
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. |
2024-01-30 |
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. |
2024-01-08 |
Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. |
2024-01-04 |
Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. |
2024-01-04 |
Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. |
2024-01-03 |
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". |
2023-12-21 |
Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". |
2023-12-20 |
LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. |
2023-12-12 |
Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen. |
2023-12-12 |
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". |
2023-11-28 |
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". |
2023-11-21 |
Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". |
2023-11-21 |
Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. |
2023-11-20 |
NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. |
2023-11-15 |
Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023". |
2023-11-13 |
Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1". |
2023-11-13 |
VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. |
2023-11-13 |
AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]". |
2023-11-09 |
Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. |
2023-11-07 |
Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. |
2023-10-23 |
High-Tech Gründerfonds Management GmbH. (10/23/23). "Press Release: FarmInsect Raises Oversubscribed €8m Series A to Commercially Scale Its Insect Farming Technology". Munich. |
2023-10-23 |
Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala. |
2023-10-17 |
Lundbeckfonden. (10/16/23). "Press Release: Venture Forces Invest Millions in New Type of Treatment for Particularly Aggressive Form of Cancer". |
2023-10-16 |
CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm. |
2023-10-14 |
Bico Group AB. (10/11/23). "Press Release: Cellink and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence". San Diego, CA. |
2023-10-11 |
Agomab Therapeutics N.V.. (10/10/23). "Press Release: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline". Ghent. |
2023-10-10 |
Circio Holding ASA. (10/10/23). "Press Release: Circio and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular RNA Therapeutics Using NICT technology". |
2023-10-10 |
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. |
2023-10-09 |
AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. |
2023-10-09 |
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. |
2023-10-04 |
PolyPeptide Group AG. (10/2/23). "Press Release: PolyPeptide Secures Revolving Credit Facility". Baar. |
2023-10-02 |
Evosep ApS. (9/28/23). "Press Release: Evosep Strengthens Leadership to Drive Scale-up". Odense. |
2023-09-28 |
AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". |
2023-09-28 |
Acesion Pharma ApS. (9/26/23). "Press Release: Acesion Pharma Closes Oversubscribed €45M Series B Financing Round". Copenhagen. |
2023-09-26 |
Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. |
2023-09-25 |
Traceless Materials GmbH. (9/25/23). "Press Release: Traceless Materials Secures €36.6 Million Series A to Build First Industry Plant for Bio-circular Alternative to Plastic". Hamburg. |
2023-09-25 |
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. |
2023-09-18 |
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. |
2023-09-12 |
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. |
2023-09-11 |
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. |
2023-09-06 |
Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. |
2023-09-05 |
BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". |
2023-09-04 |
ECBF Management GmbH. (9/4/23). "Press Release: 23 Million Euros for Sustainable Packaging Materials. ECBF Leads Paptic Financing Round". Luxembourg. |
2023-09-04 |
Embark Laboratories ApS. (8/30/23). "Press Release: Novo Nordisk Acquires Embark Biotech, including Its Lead Asset Targeting Obesity and other Cardiometabolic Diseases". Copenhagen. |
2023-08-30 |
CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. |
2023-08-29 |
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". |
2023-08-21 |
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". |
2023-08-21 |